Evidence map›Paper›PMID 38877424›Full record

ArticleCellular & molecular biology letters2024

α-Ketoglutarate alleviates osteoarthritis by inhibiting ferroptosis via the ETV4/SLC7A11/GPX4 signaling pathway.

Rong He, Yuchi Wei, Zeyu Peng, Jie Yang, Zhenwei Zhou, Ailin Li, Yongji Wu, Mingyue Wang, Xiangyan Li, Daqing Zhao and 3 more

Abstract read
In one paragraph

Article in Cellular & molecular biology letters, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Novel NDiscover oncology · 2026
    Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Rong He *College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, 130117, Jilin Province, China.
Yuchi Wei *College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, 130117, Jilin Province, China.
Zeyu PengCollege of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, 130117, Jilin Province, China.
Jie YangCollege of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, 130117, Jilin Province, China.
Zhenwei ZhouNortheast Asia Research Institute of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, 130117, Jilin Province, China.
Ailin LiCollege of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, 130117, Jilin Province, China.
Yongji WuCollege of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, 130117, Jilin Province, China.
Mingyue WangCollege of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, 130117, Jilin Province, China.
Xiangyan LiNortheast Asia Research Institute of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, 130117, Jilin Province, China.
Daqing ZhaoNortheast Asia Research Institute of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, 130117, Jilin Province, China.
Zhonghua LiuDepartment of orthopaedics, The Third Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, 130117, Jilin Province, China. 945769043@qq.com.
Haisi DongNortheast Asia Research Institute of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, 130117, Jilin Province, China. adonghaisi@163.com.ORCID http://orcid.org/0000-0003-2172-2312
Xiangyang LengCollege of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, 130117, Jilin Province, China. lengxiangy@163.com.

Funding

Innovative Research Group Project of the National Natural Science Foundation of China No. 82305274Key Laboratory in Science and Technology Development Project of Suzhou 20200201406JCScience and Technology Major Project of Jilin Province Grant number 20210304001YYthe Innovation and Entrepreneurship Talent Project of Jilin Province No. 2023DJ04the National Natural Science Foundation Regional Innovation and Development Joint Fund No. U22A20367Youth and Middle-aged Scientific and Technological Innovation Leading Talents Program of the Corps No. QT202227
6 · The paper itself

Abstract

Osteoarthritis (OA) is the most common degenerative joint disorder that causes disability in aged individuals, caused by functional and structural alterations of the knee joint. To investigate whether metabolic drivers might be harnessed to promote cartilage repair, a liquid chromatography-mass spectrometry (LC-MS) untargeted metabolomics approach was carried out to screen serum biomarkers in osteoarthritic rats. Based on the correlation analyses, α-ketoglutarate (α-KG) has been demonstrated to have antioxidant and anti-inflammatory properties in various diseases. These properties make α-KG a prime candidate for further investigation of OA. Experimental results indicate that α-KG significantly inhibited H

Indexed as

FerroptosisKetoglutaric AcidsOsteoarthritisPhospholipid Hydroperoxide Glutathione PeroxidaseSignal TransductionAmino Acid Transport System y+AnimalsApoptosisMaleProto-Oncogene Proteins c-etsRatsRats, Sprague-DawleyReactive Oxygen SpeciesAmino Acid Transport System y+glutathione peroxidase 4, ratKetoglutaric AcidsPhospholipid Hydroperoxide Glutathione PeroxidaseProto-Oncogene Proteins c-etsReactive Oxygen SpeciesETV4/SLC7A11/GPX4 signaling pathwayFerroptosisOsteoarthritisα-ketoglutarate

Identifiers

PMID38877424
PMCPMC11177415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.